Jiangxi Fushine Pharmaceutical (300497.SZ) shareholder Yu Wenjun plans to reduce his shareholding by no more than 0.82%.
Fuxiang Pharmaceutical (stock code: 300497.SZ) announced that it holds 17.6218 million shares of the company (excluding repurchases)...
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that Mr. Yu Wenjun, a specific shareholder holding 17.6218 million shares of the company (3.27% of the total share capital excluding shares in the repurchase special account), plans to reduce his holdings by a total of no more than 4.4054 million shares, or 0.82% of the total share capital excluding shares in the repurchase special account, through centralized bidding, block trades, or other methods allowed by laws and regulations within three months after the announcement date, starting from three trading days (November 19, 2024) later.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


